Follow The Filings

LIF Life360

Life360 earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by LIF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LIF insider trades
  • None no insider bought on the open market
  • $56.2M sold by 5 insiders outside a trading plan
  • $2M sold by 1 insider under 10b5-1 plans
  1. John Philip Coghlan Director
    Planned sale
    $161K 4,000 shares at $40.37 24% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  2. John Philip Coghlan Director
    Planned sale
    $168K 4,000 shares at $41.97 20% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  3. James Synge Director
    Sale
    $1.5M 33,299 shares at $44.44 15% of stake
    Traded Aug 25–26 Filed Aug 27
    ↗
  4. Chris Hulls Director
    Sale
    $11.7M 250,000 shares at $46.84 40% of stake
    Traded Aug 18 Filed Aug 19
    ↗
  5. John Philip Coghlan Director
    Planned sale
    $219K 4,000 shares at $54.82 16% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  6. John Philip Coghlan Director
    Planned sale
    $224K 4,000 shares at $56.07 14% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  7. John Philip Coghlan Director
    Planned sale
    $176K 4,000 shares at $43.99 12% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  8. John Philip Coghlan Director
    Planned sale
    $177K 4,000 shares at $44.16 11% of stake
    Traded May 1 Filed May 5
    ↗
  9. John Philip Coghlan Director
    Planned sale
    $165K 4,000 shares at $41.32 9.9% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  10. David Wiadrowski Director
    Sale
    $246K 5,957 shares at $41.34 13% of stake
    Traded Mar 13 Filed Mar 17
    ↗
  11. John Philip Coghlan Director
    Planned sale
    $185K 4,000 shares at $46.17 44% of stake
    Traded Mar 9 Filed Mar 11
    ↗
  12. Chris Hulls Director
    Sale
    $118K 1,846 shares at $63.96 100% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  13. Alex Haro Director
    Sale
    $121K 1,887 shares at $63.96 100% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  14. James Synge Director
    Sale
    $254K 3,966 shares at $63.96 100% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  15. John Philip Coghlan Director
    Planned sale
    $241K 3,125 shares at $77.22 21% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 42 option exercises, 31 sales to cover taxes, 13 stock grants, 12 share withholdings for taxes, 3 gifts, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 5 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.